tiprankstipranks
Trending News
More News >
Diatreme Resources Limited (AU:DRX)
ASX:DRX
Australian Market

Diatreme Resources Limited (DRX) AI Stock Analysis

Compare
3 Followers

Top Page

AU:DRX

Diatreme Resources Limited

(Sydney:DRX)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
AU$0.02
▼(-15.00% Downside)
The overall stock score is primarily influenced by financial performance challenges, particularly in profitability and cash flow management. Technical analysis indicates a lack of momentum, and the absence of valuation metrics further limits the stock's attractiveness.
Positive Factors
Conservative balance sheet
A strong equity base and low leverage provide durable financial flexibility for a development-stage miner. This reduces bankruptcy risk, supports multi-stage permitting and study work, and improves options to fund projects via JV, asset sales or modest debt rather than immediate heavy dilution.
Improving top-line trend
A material revenue uptick signals advancing project activity or commercial engagements. Sustained revenue growth through project de-risking supports progression to feasibility and enhances the company's ability to secure offtakes, partners or project finance over the medium term.
Clear industrial end-market focus
Targeting high-purity silica sand for glass and industrial users aligns the company with stable, structural demand. The stated monetization pathways (JV, farm-out, asset sale, offtake) allow capital-light development strategies, preserving balance sheet while accessing partner expertise and markets.
Negative Factors
Negative cash generation
Persistent negative operating and free cash flows indicate the business cannot self-fund development. Over months this raises refinancing or dilution risk, constrains exploration and permitting timelines, and increases dependence on external capital or partners to sustain project advancement.
Unprofitable operations
Ongoing negative operating margins show structural cost or scale issues typical of early-stage miners. Without a clear path to margin improvement through scale, processing or logistics gains, the company faces a prolonged timeframe to reach commercially sustainable profitability.
Volatile financial performance
Irregular revenue and inconsistent ROE undermine forecasting and make it harder to attract long-term capital or strategic partners. For a development company, this increases execution risk on permitting, financing and commercialization, potentially delaying project milestones.

Diatreme Resources Limited (DRX) vs. iShares MSCI Australia ETF (EWA)

Diatreme Resources Limited Business Overview & Revenue Model

Company DescriptionDiatreme Resources Limited engages in the exploration of heavy mineral sands, copper, gold, and base metals in Australia. The company's flagship property is the Galalar Silica Sand project located in North Queensland. Diatreme Resources Limited was incorporated in 1993 and is based in Coorparoo, Australia.
How the Company Makes MoneyDiatreme Resources Limited generates revenue primarily through the exploration and potential development of its mineral projects, particularly in silica and rare earth elements. The company's revenue model is based on the sale of extracted mineral products once the projects reach production stage. Key revenue streams include the sale of silica products to industries such as glass manufacturing, construction, and other industrial applications. The company may also engage in partnerships or joint ventures with other mining firms to enhance its exploration capabilities and share development costs. Additionally, Diatreme could benefit from securing off-take agreements with buyers, ensuring a steady demand for its products once production commences.

Diatreme Resources Limited Financial Statement Overview

Summary
Diatreme Resources Limited shows revenue growth but struggles with profitability, as evidenced by negative EBIT and EBITDA margins. The balance sheet is strong with low leverage, but cash flow issues persist, with negative operating and free cash flows.
Income Statement
45
Neutral
Diatreme Resources Limited has demonstrated volatile revenue growth, with a recent increase to $886,464 from $468,506 in 2023, indicating a significant positive trend. However, the company has consistently reported negative EBIT and EBITDA margins, reflecting operational challenges. The net profit margin has also been negative for most years, suggesting ongoing profitability issues.
Balance Sheet
60
Neutral
The company maintains a strong equity base with a high equity ratio due to substantial stockholders' equity compared to total assets. The debt-to-equity ratio is relatively low, indicating conservative leverage. However, the return on equity has been inconsistent due to fluctuating net income, posing potential concerns regarding equity efficiency.
Cash Flow
40
Negative
Cash flow analysis reveals negative operating cash flow and free cash flow, indicating cash generation challenges. The free cash flow to net income ratio is unfavorable, highlighting inefficiencies. Nevertheless, the company has managed to secure financing to support its operations, though this may not be sustainable long-term.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.00M886.46K468.51K110.14K23.94K21.28K
Gross Profit1.00M886.46K254.29K-61.14K-77.02K-50.22K
EBITDA-3.76M-4.61M10.70M-2.94M-1.94M-795.89K
Net Income45.75K-439.53K10.37M4.98M-2.15M-1.04M
Balance Sheet
Total Assets94.61M95.45M66.53M55.33M33.14M25.62M
Cash, Cash Equivalents and Short-Term Investments3.82M5.19M10.77M13.64M6.50M5.79M
Total Debt1.17M1.20M1.75M1.54M1.61M1.64M
Total Liabilities2.33M2.51M2.96M2.59M2.37M2.40M
Stockholders Equity92.27M92.94M63.57M52.75M30.76M23.22M
Cash Flow
Free Cash Flow-5.35M-7.71M-2.80M-9.57M-8.70M-4.24M
Operating Cash Flow-3.55M-6.00M-2.32M-2.51M-2.15M-1.14M
Investing Cash Flow-1.80M1.06M-462.49K-6.95M-6.57M-2.33M
Financing Cash Flow-139.71K-643.79K-86.47K16.60M9.43M6.77M

Diatreme Resources Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.02
Negative
Market Momentum
MACD
>-0.01
Neutral
RSI
100.00
Negative
STOCH
300.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DRX, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 300.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DRX.

Diatreme Resources Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
49
Neutral
AU$472.01M-20.36-140.97%
47
Neutral
AU$470.44M-11.59-12.73%2.00%8.82%
46
Neutral
AU$70.58M-29.09-9.27%35.29%
46
Neutral
AU$87.64M-0.27%-100.00%
44
Neutral
AU$126.58M-6.14-21.39%-280.00%
43
Neutral
AU$975.70M-11.21-84.61%149.43%1.20%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DRX
Diatreme Resources Limited
0.02
>-0.01
-10.53%
AU:A1G
African Gold Ltd.
0.79
0.72
1079.10%
AU:EQR
EQ Resources Limited
0.19
0.15
460.61%
AU:ASM
Australian Strategic Materials Ltd
1.57
1.09
223.71%
AU:FHE
Frontier Energy Limited
0.21
0.09
75.00%
AU:ESR
Estrella Resources Limited
0.03
0.00
0.00%

Diatreme Resources Limited Corporate Events

Diatreme Bolsters Cash Position and JV Funding After Clermont Sale and R&D Rebate
Jan 29, 2026

Diatreme Resources has strengthened its financial position in the December 2025 quarter through the sale of its Clermont Copper/Gold Project to newly listed Moonlight Resources, in which it now holds a 16.76% stake. The transaction delivered $3.25 million in Moonlight shares and $250,000 in cash, while the company also received an R&D tax incentive refund of $226,894 related to its Cyclone Zircon Project and plans further claims for 2025 expenditure. Diatreme reported total cash and liquid assets of $7.7 million at 31 December 2025, including $5.4 million held within its silica project joint venture, providing additional funding runway as it advances its mineral sands and silica initiatives and continues investor engagement, including a CEO presentation at the Noosa Mining Investor Conference.

The most recent analyst rating on (AU:DRX) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.

Diatreme Resources Advances Northern Silica Project with DEIS Submission
Dec 14, 2025

Diatreme Resources Limited has submitted the Draft Environmental Impact Statement (DEIS) for its Northern Silica Project to Queensland’s Office of the Coordinator-General. This submission marks a significant milestone in the project’s approval process, highlighting its potential to deliver economic benefits and support the clean energy transition. The DEIS, prepared after extensive investigations, outlines the project’s scope, potential impacts, and mitigation strategies, paving the way for public consultation and review in 2026. The project promises new employment and investment opportunities for the Hope Vale/Cooktown region while managing environmental and cultural impacts.

The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.

Diatreme Resources’ Stake in Moonlight Resources Debuts on ASX
Dec 11, 2025

Diatreme Resources Limited announced that Moonlight Resources Ltd, where it holds a 16.8% stake, has been listed on the Australian Securities Exchange. This follows Moonlight’s acquisition of Chalcophile Resources Pty Ltd and PGE Minerals Pty Ltd, which own the Clermont Gold Project. Moonlight has commenced drilling at the project, aiming for a Mineral Resource Estimate with results expected in Q1 2026. The IPO raised A$10 million, with Diatreme receiving shares and cash, and retaining the right to appoint a director to Moonlight’s board.

The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.

Diatreme Resources Finalizes Sale of Clermont Gold Project
Dec 5, 2025

Diatreme Resources Limited has completed the sale of its Clermont Gold Project to Moonlight Resources Limited, receiving $3.25 million in Moonlight shares and $250,000 in cash. This transaction makes Diatreme a significant shareholder in Moonlight, with the right to appoint a director to Moonlight’s board, and it aligns with Moonlight’s upcoming IPO and ASX listing.

The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.

Diatreme Resources Maintains Steady Production Targets Amidst Global Silica Demand
Nov 13, 2025

Diatreme Resources Limited announced that their resource estimates and production targets remain unchanged as of June 2025, with no new information affecting previous announcements. The company emphasizes the importance of securing project development finance and attracting financial partners to meet production targets, highlighting the ongoing demand for high purity silica sand in the market.

Diatreme Resources Director Acquires Significant Shareholding
Nov 11, 2025

Diatreme Resources Limited announced a change in the director’s interest, with Karalyn Keys acquiring 2,546,253 ordinary shares through an on-market trade. This acquisition reflects a significant investment in the company, potentially indicating confidence in its future prospects and impacting its market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025